|Anti-Influenza A hemagglutinin Recombinant Antibody
- Product Overview
- Recombinant human monoclonal antibody expressed in CHO binding to Influenza A hemagglutinin. CR6261 is a monoclonal antibody that binds to a broad range of the influenza virus. Based upon the conservation of the amino acid sequence on this part of hemagglutinin, CR6261 is predicted to neutralize roughly 50% of all flu viruses.
- Influenza A hemagglutinin
- The details of the immunogen for this antibody are not available.
- Species Reactivity
- influenza virus
- Suitable for use in ELISA, FC, IP, FuncS, IF, Neut, IHC and most other immunological methods.
- Predicted N terminal
- Molecular Weight
- Approximately 150 kDa
- >95.0% as determined by analysis by RP-HPLC.
- At -20°C for one year.
- Influenza A (H1N1) virus is a subtype of influenza A virus and was the most common cause of human influenza (flu) in 2009. Some strains of H1N1 are endemic in humans and cause a small fraction of all influenza-like illness and a small fraction of all seasonal influenza. H1N1 strains caused a few percent of all human flu infections in 2004–2005Other strains of H1N1 are endemic in pigs (swine influenza) and in birds (avian influenza).
- Antigen Description
- Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes.
- Influenza A Hemagglutinin; Influenza A; H1N1; Group V ((-)ssRNA); Orthomyxoviridae; S-OIV A Hemagglutinin; Swine flu H1
All listed customized services & products are for research use only, not intended for pharmaceutical, diagnostic, therapeutic or any in vivo human use.